NUS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NU Skin Enterprises Inc (NUS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's recent financial performance shows significant declines in revenue, net income, and EPS, which are major red flags. Additionally, there are no strong positive trading signals or catalysts to justify immediate investment. While the technical indicators are neutral and options data suggests bearish sentiment, the lack of positive momentum and weak financials make this stock a hold for now.
The MACD is positive but contracting, RSI is neutral at 57.83, and moving averages are converging, indicating no clear trend. Key support and resistance levels are at S1: 7.187 and R1: 7.825, with the pre-market price at 7.66, slightly above the pivot point of 7.506. Overall, the technical indicators suggest a neutral trend.
Gross margin increased by 12.91% YoY to 70.74, which is a positive sign for operational efficiency.
Additionally, there is no recent news, no significant hedge fund or insider activity, and no recent congress trading data.
In Q4 2025, the company's revenue dropped to $370.32M (-16.89% YoY), net income dropped to $14.49M (-140.14% YoY), and EPS dropped to $0.29 (-139.73% YoY). However, gross margin improved to 70.74 (+12.91% YoY). Overall, the financial performance is weak with declining profitability and growth metrics.
No recent analyst rating or price target changes are available for NUS.
